Related Articles
Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro
Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo
Establishment and characterization of the gemcitabine‑resistant human pancreatic cancer cell line SW1990/gemcitabine
Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition
Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer